Caution Notice:
It has come to our notice that certain fraudulent individuals or entities are misusing our Company’s name and TCI’s registered trademarks by promoting and offering for sale regulated and hazardous chemical substances, including Potassium Cyanide, through online platforms like YouTube. We hereby categorically clarify that TCI has no association or connection whatsoever with the products being displayed or sold in these or similar videos. These products have been falsely represented as being associated with TCI, and the unauthorized use of our trademark and brand name is both illegal and misleading. TCI Chemicals is a responsible global organization committed to adhering to all applicable international and domestic regulatory frameworks. We do not manufacture, distribute, or engage in the sale of regulated chemical substances in India or in any other jurisdiction unless specifically authorized by the relevant laws and regulatory agencies. All our operations and offerings are governed by stringent safety, quality, and compliance protocols in accordance with applicable laws. Further, TCI Chemicals markets and sells its products exclusively through its official website and authorized distributors. We do not sell, endorse, or supply our products through any third-party platforms, unauthorized agents, or resellers. Any individual or organization purchasing products outside these official channels does so at their own risk, and TCI disclaims all responsibility and liability for any consequences arising therefrom. Members of the public, customers, and partners are strongly advised to exercise caution and conduct due diligence before engaging in any transactions involving products claiming association with TCI Chemicals. The official list of our authorized distributors is publicly available and may be accessed at: https://www.tcichemicals.com/IN/en/distributor/index. We are currently pursuing appropriate legal remedies against those misusing our brand, and we reserve all rights available to us under applicable intellectual property and criminal laws. If you become aware of any such fraudulent activity or require clarification, you may reach out to us at: Sales-IN@TCIchemicals.com. Your vigilance and cooperation are essential in safeguarding the public interest and protecting the integrity of the TCI brand.
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 506-32-1 | Product Number: A0781
Arachidonic Acid
×
![]()
×
Purity: >98.0%(GC)(T)
Synonyms:
- 5,8,11,14-Eicosatetraenoic Acid
- 5,8,11,14-Icosatetraenoic Acid
- (5Z,8Z,11Z,14Z)-5,8,11,14-Eicosatetraenoic Acid
Product Documents:
| Size | Unit Price | Hyderabad | Japan* | Quantity |
|---|---|---|---|---|
| 100MG |
₹8,000.00
|
7 | ≥100 |
|
| 500MG |
₹25,700.00
|
Contact Us | 32 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
| Product Number | A0781 |
| Purity / Analysis Method | >98.0%(GC)(T) |
| Molecular Formula / Molecular Weight | C__2__0H__3__2O__2 = 304.47 |
| Physical State (20 deg.C) | Liquid |
| Storage Temperature | Frozen (<0°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Light Sensitive,Air Sensitive,Heat Sensitive |
| Packaging and Container | 100MG-Ampule (View image), 500MG-Ampule (View image) |
| CAS RN | 506-32-1 |
| Reaxys Registry Number | 1913991 |
| PubChem Substance ID | 87562313 |
| SDBS (AIST Spectral DB) | 7566 |
| Merck Index (14) | 765 |
| MDL Number | MFCD00004417 |
Specifications
| Appearance | Colorless to Light yellow to Light orange clear liquid |
| Purity(GC) | min. 98.0 % |
| Purity(Neutralization titration) | min. 98.0 % |
Properties (reference)
| Specific Gravity (20/20) | 0.92 |
| Refractive Index | 1.49 |
| Solubility in water | Insoluble |
GHS
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H315 : Causes skin irritation. H319 : Causes serious eye irritation. |
| Precautionary Statements | P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ eye protection/ face protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. |
Related Laws:
| RTECS# | CE6675000 |
Transport Information:
Application
Reagent for platelet aggregation model
References
- Arachidonic acid induced mortality in animals - an appropriate model for the evaluation of antithrombotic drugs?
- F. Seuter, W. D. Busse, Agents Actions Suppl. 1979, 4, 175.
- Influence of aspirin, molsidomine, trapidil, and some trapidil derivatives on arachidonic acid induced reversible thrombocyte aggregation in the rabbit
- U. Zehl, H. J. Mest, W. Förster, Biomed. Biochim. Acta. 1984, 43, 381.
Application
Reagent for acute inflammatory (ear edema) model
References
- The mouse ear inflammatory response to topical arachidonic acid
- Effect of anti-inflammatory compounds on edema formation and myeloperoxidase activity in the arachidonic acid-induced ear model in the mouse
- Inhibition of arachidonic acid-induced ear oedema as a model for assessing topical anti-inflammatory compounds
- ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model
Application
Reagents for cerebral infarction model
References
- Arachidonate-induced cerebrovascular occlusion in the rat. The role of platelets and aspirin in stroke
- The sodium arachidonate-induced cerebral infarct in the rat: a model for the study of drugs
- J. Cahn, M. G. Borzeix, J. Cereb. Blood Flow Metab. 1982, 2 Suppl 1, 74.
Application
Reagent for conjunctivitis model
References
- Effects of bromfenac sodium, non-steroidal anti-inflammatory drug, on acute ocular inflammation
- T. Ogawa, T. Sakaue, T. Terai, O. Fukiage, Nihon Ganka Gakkai Zasshi, 1995, 99, 406.
- Topical arachidonic acid: a model for screening anti-inflammatory agents
- Effects of sodium naproxen eye drops on rabbit ocular inflammation induced by sodium arachidonate
- Differential inflammatory effects of arachidonic acid on rabbit conjunctiva and iris: a possible role of lipoxygenase in the conjunctival response
- P. Bhattacherjee, P. S. Kulkarni, K. E. Eakins, Adv. Prostaglandin Thromboxane Res. 1980, 8, 1727.
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.